NEW YORK, Sept. 28 - Aptus Genomics, a biotech company that focuses on G-protein coupled receptor genes, has appointed Krystyna Belendiuk as president, the company said on Friday. 

"I am very pleased to have someone with Krystyna's knowledge and experience join the Aptus management team," Kevin Chance, founder and CEO of Aptus, said in a statement. 

Before joining Aptus, Belendiuk was co-founder, director, and senior vice president of Pharmavene, now known as Shire Laboratories.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.